News & Insights

Laboratory real estate is evolving into one of the most complex and mission-critical infrastructure asset classes in Europe. As part of a recent expert panel hosted by Potsdam Science Park on “Safety in Laboratory Operations and Laboratory Design,” HELIX alpha contributed perspectives from an investor and developer standpoint on the structural transformation currently shaping the European life science real estate market. The discussion focused on several key tensions increasi

HELIX alpha holds regular meetings between its Investment & Risk Committee and Advisory Board throughout the year, complemented by an annual in-person session. The most recent meeting took place in Hamburg. The session focused on reviewing and further refining the core premises of HELIX alpha’s investment strategy. Particular emphasis was placed on the continued focus on both emerging and established life science clusters across Europe as the foundation for disciplined invest

As part of its pan-European investment strategy, HELIX alpha actively engages with leading life science clusters to build direct relationships with key ecosystem stakeholders. In this context, HELIX alpha recently visited the Stockholm life science cluster together with its local Country Representative. The exchange included meetings with senior representatives of established cluster organisations, providing on-the-ground insights into one of Europe’s most advanced and intern

HELIX alpha participated as an official partner in a recent industry event on Life Science Real Estate (LSRE) hosted by Heuer Dialog. The conference highlighted the growing institutional relevance of LSRE as an emerging and structurally differentiated asset class. The discussions reflected a holistic perspective across the value chain – from market analysis and development expertise to user requirements and cluster dynamics. In particular, the role of established and emerging

HELIX alpha CEO Martin Eberhardt has contributed an article to the current issue of the FondsForum Magazin , a publication dedicated to knowledge and strategic perspectives for the institutional real estate industry. The article, titled “Life Sciences Real Estate: Resilience and Impact,” examines the growing strategic relevance of Life Sciences Real Estate (LSRE) as an emerging asset class for institutional investors. In a market environment characterised by economic volati

Laboratory buildings are among the most complex real estate assets today. They combine sensitive data, valuable research infrastructure and safety-critical operations while facing increasing regulatory, technical and digital requirements. Ensuring safety in laboratory environments therefore requires an integrated approach that connects architecture, building operations and digital resilience.

In a recent interview with the leading German real estate industry magazine immobilienmanager , Martin Eberhardt, Managing Partner of HELIX alpha, discusses the company’s strategy and its vision for building a pan-European Life Science Real Estate platform. The conversation highlights the importance of local market expertise, the growing relevance of life science ecosystems and the opportunities arising from the ongoing transformation of the real estate industry. Read the ful

HELIX alpha is partner of the event "Life Science Immobilien" with Heuer Dialog

In Zeiten der Unsicherheit sind Anleger auf der Suche nach Anlageklassen, die Substanz besitzen und zukunftsträchtig sind. Martin Eberhardt FRICS behandelt in seinem Beitrag „Life Science Real Assets – Strategischer Stabilitätsanker für institutionelle Investoren“ für die Property Post dieses Thema. Im Mittelpunkt stehen hochspezialisierte Immobilien wie Labore, Forschungszentren oder Produktionsstätten, die von Megatrends wie demografischem Wandel, personalisierter Medizi

Throughout his career, Martin Eberhardt has been fortunate to pioneer emerging real estate asset classes – from Student Housing, Communication Infrastructure to Car Parks – identifying their potential long before they became mainstream. Today, he sees the same compelling dynamics in Life Sciences Real Estate (LSRE). In his latest article, he outlines why LSRE should no longer be considered a niche but a strategic portfolio component: Resilient returns in volatile, challenging